July 22, 2021 07:23 AM EDTUpdated July 27, 04:52 PM

Covid-19 roundup: Regeneron asks FDA: Which government agencies are tracking variants of concern?; Pfizer, AstraZeneca vaccines mostly hold strong against Delta variant

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

As the race to keep Covid-19 variants at bay continues, Regeneron is calling on the FDA to provide additional clarity on which government agencies are …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Regeneron asks FDA: Which government agencies are tracking variants of concern?; Pfizer, AstraZeneca vaccines mostly hold strong against Delta variant

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

Covid-19 roundup: Re­gen­eron asks FDA: Which gov­ern­ment agen­cies are track­ing vari­ants of con­cern?; Pfiz­er, As­traZeneca vac­cines most­ly hold strong against Delta vari­ant

Editor

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: Regeneron asks FDA: Which government agencies are tracking variants of concern?; Pfizer, AstraZeneca vaccines mostly hold strong against Delta variant